The Effects of Topical Antiglaucoma Drugs as Monotherapy on the Ocular Surface: A Prospective Study

Table 3

Squamous metaplasia grades in the inferior-nasal conjunctiva according to the groups.

Squamous metaplasia; Inferior quadrant	Group 1	Group 2	Group 3	Group 4	Group 5	Group 6	𝑃
Before	0.16 ± 0.25	0.21 ± 0.42	0.42 ± 0.51	0.28 ± 0.46	0.11 ± 0.26	0.28 ± 0.46	χ²: 7.92; 𝑃=0.161
3rd month	0.53 ± 0.51	0.50 ± 0.65	0.57 ± 0.51	0.21 ± 0.42	0.35 ± 0.49	0.57 ± 0.75	χ²: 4.50; 𝑃=0.479
6th month	0.40 ± 0.50	0.64 ± 0.49	0.57 ± 0.51	0.21 ± 0.42	0.28 ± 0.46	0.57 ± 0.75	χ²: 7.29; 𝑃=0.200
12th month	0.53 ± 0.63	0.57 ± 0.51	0.71 ± 0.46	0.21 ± 0.42	0.28 ± 0.46	0.50 ± 0.65	χ²: 8.87; 𝑃=0.114
𝑃	0.001	0.013	0.096	0.392	0.029	0.019
Before 3rd month	0.008	0.046	0.157	0.317	0.046	0.046
Before 6th month	0.025	0.014	0.157	0.317	0.083	0.046
Before 12th month	0.008	0.025	0.083	0.317	0.083	0.083